Xue Ke
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 7
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 9
- Co-authors
- Tianyuan Ci (14 shared papers)Hao Wu (3 shared papers)Haifeng Sun (4 shared papers)Dinglingge Cao (4 shared papers)Yi Chen (2 shared papers)Jilai Tian (3 shared papers)Danrong Hu (3 shared papers)Yueyang Deng (3 shared papers)
- Journals
- International Journal of Biological Macromolecules (3 papers)International Journal of Pharmaceutics (3 papers)Journal of drug targeting (3 papers)Experimental Mechanics (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xue Ke
32 papers receiving 878 citations
Peers
Comparison fields: 5 of 97
- Biomaterials 354
- Pharmaceutical Science 132
- Molecular Medicine 75
- Biomedical Engineering 314
- Pharmacology 60
Countries citing papers authored by Xue Ke
This map shows the geographic impact of Xue Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Ke more than expected).
Fields of papers citing papers by Xue Ke
This network shows the impact of papers produced by Xue Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Ke. The network helps show where Xue Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Xue Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 103 | |
| 2 | 2017 | 95 | |
| 3 | 2014 | 72 | |
| 4 | 2016 | 54 | |
| 5 | 2013 | 49 | |
| 6 | 2020 | 45 | |
| 7 | 2019 | 42 | |
| 8 | 2015 | 40 | |
| 9 | 2018 | 36 | |
| 10 | 2012 | 35 | |
| 11 | 2022 | 32 | |
| 12 | 2014 | 31 | |
| 13 | 2018 | 27 | |
| 14 | 2011 | 26 | |
| 15 | 2017 | 25 | |
| 16 | 2012 | 25 | |
| 17 | 2018 | 22 | |
| 18 | 2016 | 14 | |
| 19 | 2020 | 13 | |
| 20 | 2023 | 10 |
About Xue Ke
Xue Ke is a scholar working on Molecular Biology, Biomaterials, Pharmaceutical Science, Biomedical Engineering and Polymers and Plastics, having authored 34 papers that have together received 885 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), RNA Interference and Gene Delivery (7 papers), Nanoplatforms for cancer theranostics (6 papers), Drug Solubulity and Delivery Systems (6 papers), Crystallization and Solubility Studies (4 papers), Dendrimers and Hyperbranched Polymers (4 papers), Advanced Drug Delivery Systems (4 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Biomaterials (354 citations), Pharmaceutical Science (132 citations), Molecular Medicine (75 citations), Biomedical Engineering (314 citations) and Pharmacology (60 citations). Xue Ke has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Tianyuan Ci, Hao Wu, Haifeng Sun, Dinglingge Cao, Yi Chen, Jilai Tian, Danrong Hu, Yueyang Deng, Haohuan Li and Xingxian Zhang. Their work appears in journals such as International Journal of Biological Macromolecules, International Journal of Pharmaceutics, Journal of drug targeting, Experimental Mechanics and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.